Humanigen Inc (HGENQ)

[cowtown jay]

They're doctors, in addition to being MBA's. They HAD TO focus their effort on treating covid pneumonia, as covid has killed almost 7 million people in the last three years. They have done everything they needed to do to get regulatory approval for this treatment. My only question now is whether they are going to wait for Australian approval of lenz to treat CMML, before they resubmit their covid EUA application to the FDA.

Maybe there are some Big Pharma competitors that think Humanigen is too small to handle a covid product that has that big of a bang for the buck.

But there are other vaccine makers who may recognize that using their vaccine in a cocktail with lenz and an anti-viral, could enable them to take market share away from Pfizer and Moderna. Maybe those smaller vaccine makers also recognize that this cocktail would negate the need for perpetual trials, because lenz is variant-agnostic. And if the anti-viral being used in this cocktail is brilacidin, then their vaccine may be used to prevent both upper and lower respiratory tract infections, AND, the cocktail may be able to treat, not only new strains and variants of SARs-CoV-2, but other TYPES of coronavirus, as well, such as SARS and MERS.

I think Humanigen is rightly focused on using their patented lenz/vaccine/anti-viral cocktail, and thereby expanding our patient population by using lenz as a covid preventative, as well as a treatment for covid pneumonia.